- Report
- January 2026
- 265 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 271 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 376 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 199 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 403 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 360 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 391 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 262 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 183 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 762 Pages
Global
From €5160EUR$5,800USD£4,477GBP
- Report
- January 2026
- 182 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 192 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 196 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 182 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 196 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 196 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 181 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 194 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 282 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 274 Pages
Global
From €5204EUR$5,850USD£4,515GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more